Diclogen NDC 59088-802

NDC codes

FDA NDC Directory

Product NDC (as listed)59088-802Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59088-0802Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59088-802-00	59088080200	1 KIT in 1 KIT (59088-802-00) * 1 BOTTLE, DROPPER in 1 CARTON (59088-435-10) / 150 mL in 1 BOTTLE, DROPPER * 85 g in 1 BOTTLE, WITH APPLICATOR (59088-283-07)Marketed from Jul 26, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diclogen
Generic name (nonproprietary): diclofenac sodium, camphor and menthol
Dosage form: Kit
Labeler: PureTek Corporation
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jul 26, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 59088-802_463c7ec1-4f7d-598c-e063-6394a90a6d8dSPL ID 463c7ec1-4f7d-598c-e063-6394a90a6d8dSPL set ID 1e2bb4e5-bb65-48a0-e063-6294a90a54d1RxCUI 857700, 1039731

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N459088080200 followed by a unit qualifier and the quantity

Package 59088-0802-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Diclofenac sodium topical solution, USP is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s) (1). Diclofenac sodium topical solution is a nonsteroidal anti-inflammatory drug indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s). ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)